These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34556086)

  • 1. IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma.
    Zhao W; Cui M; Zhang R; Shen X; Xiong X; Ji X; Tao L; Jia W; Pang L; Sun Z; Wang C; Zou H
    BMC Cancer; 2021 Sep; 21(1):1047. PubMed ID: 34556086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus.
    Busca A; Gulavita P; Parra-Herran C; Islam S
    Int J Gynecol Pathol; 2018 Jul; 37(4):372-378. PubMed ID: 28700435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
    Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
    Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics: the IFITM1 model.
    Parra-Herran CE; Yuan L; Nucci MR; Quade BJ
    Mod Pathol; 2014 Apr; 27(4):569-79. PubMed ID: 24072182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Highly cellular leiomyoma of uterus: a comparative morphologic and immunohistochemical study of endometrial stromal tumors].
    Liao X; Wang Y; Yue C; Liu Y; Wang H; Dai L; Hui Y
    Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):396-400. PubMed ID: 12485478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of CD10 and h-Caldesmon in the distinction of smooth muscle tumors of the uterus and endometrial stromal sarcoma.
    Saraydaroglu O; Ozuysal S; Kasap M; Ozerkan K
    Saudi Med J; 2008 Sep; 29(9):1349-50. PubMed ID: 18813428
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus].
    Farah-Klibi F; Ben Hamouda S; Ben Romdhane S; Sfar R; Koubaa A; Ben Jilani S; Zermani R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Sep; 37(5):457-62. PubMed ID: 18565690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.
    Hwang H; Matsuo K; Duncan K; Pakzamir E; Pham HQ; Correa A; Fedenko A; Mhawech-Fauceglia P
    J Clin Pathol; 2015 Sep; 68(9):710-7. PubMed ID: 25991737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
    Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
    Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody.
    Sumathi VP; Al-Hussaini M; Connolly LE; Fullerton L; McCluggage WG
    Int J Gynecol Pathol; 2004 Jul; 23(3):241-7. PubMed ID: 15213600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
    Oliva E; Young RH; Amin MB; Clement PB
    Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant].
    Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M
    Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma.
    Agoff SN; Grieco VS; Garcia R; Gown AM
    Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):164-9. PubMed ID: 11396634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma.
    Rush DS; Tan J; Baergen RN; Soslow RA
    Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
    Chu PG; Arber DA; Weiss LM; Chang KL
    Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFITM1 Is Superior to CD10 as a Marker of Endometrial Stroma in the Evaluation of Myometrial Invasion by Endometrioid Adenocarcinoma.
    Busca A; Djordjevic B; Giassi A; Parra-Herran C
    Am J Clin Pathol; 2016 Apr; 145(4):486-96. PubMed ID: 27124937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
    Yilmaz A; Rush DS; Soslow RA
    Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
    Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
    Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed tumors of the vagina: an immunohistochemical study of 13 cases with emphasis on the cell of origin and potential aid in differential diagnosis.
    Oliva E; Gonzalez L; Dionigi A; Young RH
    Mod Pathol; 2004 Oct; 17(10):1243-50. PubMed ID: 15154010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
    Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
    Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.